Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP cut its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 74.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 28,876 shares of the health services provider's stock after selling 83,930 shares during the quarter. Bridgewater Associates LP's holdings in Teladoc Health were worth $262,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after buying an additional 56,864 shares during the last quarter. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Smith Anglin Financial LLC purchased a new position in shares of Teladoc Health in the 4th quarter worth about $108,000. Arkadios Wealth Advisors acquired a new position in shares of Teladoc Health in the 4th quarter valued at about $115,000. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Stock Up 2.5 %

TDOC stock traded up $0.18 during mid-day trading on Thursday, hitting $7.25. 2,689,695 shares of the company were exchanged, compared to its average volume of 6,249,964. The firm has a fifty day simple moving average of $8.78 and a 200 day simple moving average of $9.59. The company has a market capitalization of $1.27 billion, a PE ratio of -1.26 and a beta of 1.73. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.95% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on TDOC. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Piper Sandler lowered their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Bank of America reduced their price objective on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Finally, Jefferies Financial Group decreased their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $10.82.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.